Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Irritable Bowel Syndrome

  Free Subscription


1 Aliment Pharmacol Ther
1 Aten Primaria
1 Commun Biol
1 Complement Med Res
1 Diagnostics (Basel)
1 Digestion
1 Drugs Real World Outcomes
1 Eur J Immunol
1 Expert Opin Investig Drugs
1 Front Microbiol
1 Front Nutr
1 Gut
1 Gut Liver
2 J Am Acad Dermatol
1 J Clin Invest
1 J Clin Med
1 J Gastroenterol Hepatol
1 Neurogastroenterol Motil
2 Nutrients
1 Res Sq

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. STAUDACHER HM, Mahoney S, Canale K, Opie RS, et al
    Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2023 Nov 15. doi: 10.1111/apt.17791.
    PubMed         Abstract available

    Aten Primaria

  2. RAMIREZ ARANDA JM, Martinez Gutierrez CM, Fuentes Ramirez MM, Escobedo Rios MR, et al
    [Familial aggregation in Irritable Colon Syndrome in Mexican patients. A case-control study].
    Aten Primaria. 2023;56:102794.
    PubMed         Abstract available

    Commun Biol

  3. MAS-OREA X, Rey L, Battut L, Bories C, et al
    Proenkephalin deletion in hematopoietic cells induces intestinal barrier failure resulting in clinical feature similarities with irritable bowel syndrome in mice.
    Commun Biol. 2023;6:1168.
    PubMed         Abstract available

    Complement Med Res

    The Tibetan formula Cong zhi 6 in the ORL (ENT) practice: Experiences with laryngopharyngeal reflux (LPR).
    Complement Med Res. 2023 Nov 11. doi: 10.1159/000534212.
    PubMed         Abstract available

    Diagnostics (Basel)

  5. VULPOI RA, Luca M, Ciobanu A, Olteanu A, et al
    The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management.
    Diagnostics (Basel). 2023;13:3336.
    PubMed         Abstract available


  6. KYODO R, Kudo T, Ito N, Tokita K, et al
    Modulation of Intestinal Motility in an Adolescent Rat Model of Irritable Bowel Syndrome.
    Digestion. 2023 Nov 14:1-8. doi: 10.1159/000534732.
    PubMed         Abstract available

    Drugs Real World Outcomes

  7. HERNANDEZ-VELASQUEZ DA, Rodriguez-Martinez E, Montoya-Meneses JD, Gonzalez-Ceballos JS, et al
    Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study.
    Drugs Real World Outcomes. 2023 Nov 15. doi: 10.1007/s40801-023-00395.
    PubMed         Abstract available

    Eur J Immunol

  8. FLOOD P, Hanrahan N, Nally K, Melgar S, et al
    Human intestinal organoids: modelling gastrointestinal physiology and immunopathology - current applications and limitations.
    Eur J Immunol. 2023 Nov 13:e2250248. doi: 10.1002/eji.202250248.
    PubMed         Abstract available

    Expert Opin Investig Drugs

  9. PLASSE TF, Fathi R, Fehrmann C, McComsey GA, et al
    Upamostat: a serine protease inhibitor for antiviral, gastrointestinal and anticancer indications.
    Expert Opin Investig Drugs. 2023 Nov 16. doi: 10.1080/13543784.2023.2284385.
    PubMed         Abstract available

    Front Microbiol

  10. LIU W, Fan X, Jian B, Wen D, et al
    The signaling pathway of hypoxia inducible factor in regulating gut homeostasis.
    Front Microbiol. 2023;14:1289102.
    PubMed         Abstract available

    Front Nutr

  11. GARCIA-ETXEBARRIA K, Gayoso L, Arzallus T, Montalvo I, et al
    A 1 year course of starch- and sucrose-reduced diet used by irritable bowel syndrome patients with diarrhoea and the effect of genetic variants.
    Front Nutr. 2023;10:1268538.
    PubMed         Abstract available


  12. TUN HM, Peng Y, Massimino L, Sin ZY, et al
    Gut virome in inflammatory bowel disease and beyond.
    Gut. 2023 Nov 10:gutjnl-2023-330001. doi: 10.1136/gutjnl-2023-330001.
    PubMed         Abstract available

    Gut Liver

  13. KIM KW
    Comments on Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gut Liver. 2023;17:954-955.

    J Am Acad Dermatol

  14. KRIDIN K, Ludwig RJ
    Isotretinoin is not associated with inflammatory bowel disease even when compared to topical antibiotics and topical retinoids.
    J Am Acad Dermatol. 2023 Nov 9:S0190-9622(23)03184.

  15. LIN CY, Yao CA
    Antibiotics used to treat acne may be associated with inflammatory bowel disease: response to Kridin et al.'s "Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study".
    J Am Acad Dermatol. 2023 Nov 9:S0190-9622(23)03183.

    J Clin Invest

  16. WU Q, Badu S, So SY, Treangen TJ, et al
    The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease.
    J Clin Invest. 2023 Nov 14:e170859. doi: 10.1172/JCI170859.
    PubMed         Abstract available

    J Clin Med

  17. BIANCO A, Russo F, Franco I, Riezzo G, et al
    Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise.
    J Clin Med. 2023;12:6786.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  18. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    PubMed         Abstract available

    Neurogastroenterol Motil

  19. BAART AM, Mensink M, Witteman BJM
    The impact of running on gastrointestinal symptoms in patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Nov 14:e14707. doi: 10.1111/nmo.14707.
    PubMed         Abstract available


  20. TORBICA A, Vujasinovic V, Radosavljevic M, Radivojevic G, et al
    FODMAPs-Unknowns for Consumers: First Survey in Serbia.
    Nutrients. 2023;15:4693.
    PubMed         Abstract available

  21. LINSALATA M, Riezzo G, Orlando A, D'Attoma B, et al
    The Role of Intestinal Barrier Function in Overweight Patients with IBS with Diarrhea Undergoing a Long-Term Low Fermentable Oligo-, Di-, and Monosaccharide and Polyol Diet.
    Nutrients. 2023;15:4683.
    PubMed         Abstract available

    Res Sq

  22. RUSSO S, Chan K, Li L, Parise L, et al
    Stress-activated brain-gut circuits disrupt intestinal barrier integrity and social behaviour.
    Res Sq. 2023 Oct 27:rs.3.rs-3459170. doi: 10.21203/rs.3.rs-3459170.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.